BELLEFONTE, PA – Actuated Medical, Inc. has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Institutes of Health – National Institute of Neurological Disorders and Stroke (NIH-NINDS) entitled “Development of a miniaturized wearable ultrasonic beam-forming device for localized targeting of brain regions in freely moving experimental subjects.” This project intends to commercialize an innovative ultrasound beamforming technology that was first developed under a BRAIN initiative-funded exploratory research grant (R21EY029424) led by Dr. Mehdi Kiani, Associate Professor in the Department of Electrical Engineering at The Pennsylvania State University. The system will be the first commercially available transcranial focused ultrasound system. Long term project goals, include feasibility studies for therapeutic treatment of conditions like Parkinson’s disease.
“In collaboration with Actuated Medical, I am confident that a novel technology will be developed that will benefit neuroscience researchers to study brain functions with low-intensity focused ultrasound pulses.” Dr. Mehdi Kiani, Associate Professor, The Pennsylvania State University.
“Actuated Medical’s goal is to be a leader in developing and commercializing innovative neuroscience technologies that will help to treat patients with neurological conditions. We are excited to be a partner with Dr. Kiani to bring this technology to researchers that are focused on understanding the brain.” Maureen L. Mulvihill, Actuated Medical President, CEO, and Co-Founder.